Clinical and Molecular Evidence for c-kit Receptor as a Therapeutic Target in Neuroblastic Tumors
Stefania Uccini(Sapienza University of Rome), Carlo Dominici(Sapienza University of Rome)
Cited by 38
Related Papers
Crizotinib-induced antitumour activity in human alveolar rhabdomyosarcoma cells is not solely dependent on ALK and MET inhibition
|Journal of Experimental & Clinical Cancer Research|2015|55
PARP inhibitors affect growth, survival and radiation susceptibility of human alveolar and embryonal rhabdomyosarcoma cell lines
|Journal of Cancer Research and Clinical Oncology|2018|35
Morphological and molecular assessment of apoptotic mechanisms in peripheral neuroblastic tumours
|British Journal of Cancer|2006|6